(HealthDay)—For patients with coronary artery disease (CAD), those enrolled in Medicare Advantage (MA) are more likely to receive secondary prevention treatments than those enrolled in traditional fee-for-service (FFS) Medicare, according to a study published online Feb. 20 in JAMA Cardiology.
source https://www.lifetechnology.com/blogs/life-technology-news-blog/odds-of-receiving-tx-for-cad-up-with-medicare-advantage